Showing 1 - 10 of 10 results
Earn CPD credits from a series of online exams covering hypoglycaemia, impact of poor glucose control and effective insulin therapy
would mean funding decisions by bodies, such as NICE, would have to be made within 120 days for new drugs ( GP , 11 April ). As we reveal today, this may be a problem for NICE because just 23% of single ... the GPC and Cancer Research UK warned that imposing strict deadlines on NICE's decisions could force ...
NHS patients wait more than five years to receive new medicines because NICE misses its own...The Office for Health Economics found that NICE missed its 301-day target for individual medicines in 77% of cases in the past decade. NICE also breached a 420-day target for multiple drugs in 81% of its appraisals. Appeals and legal challenges outside of NICE's control added to the delays ...
and feeling full quickly. 4 NICE guidance agrees with this and suggests that symptoms of increased ... by the clinical absence of a pelvic mass. Initial investigations NICE guidance recommends preliminary ... transvaginal USS). If the CA125 is within normal limits ( 35IU/ml), NICE recommends careful assessment ...
, but this paper is very informative. Guidelines NICE and SIGN have published comprehensive guidelines, although their evidence and references can be difficult to find. NICE. The management of bacterial ... and secondary care. London, NICE, 2010 . A 45-page practical plan for the management of all children ...
for proton beam therapy. The treatment hasn't yet been appraised by NICE, and a US study shows that men ...
the usual two-year NICE appraisal process. The targets aim to avoid inappropriate referrals and emergency ...
and an improvement in symptoms. 6 Anti-IgE monoclonal antibody (omalizumab) NICE recommends omalizumab ... on the management of asthma 2008: a national clinical guideline; updated January 2012. 7. NICE. Omalizumab for severe persistent allergic asthma. TA133. London, NICE,2007. www.nice.org.uk/nicemedia/pdf/TA133Guidance ...
to their high cost, these agents are restricted, according to NICE, to those patients who have failed to respond ... . Oxford, Blackwell Publishing, 2008. 6. NICE. Psoriatic arthritis - etanercept, infliximab and adalimumab. TA199. London, NICE, 2010. CPD IMPACT: EARN MORE CREDITS ...
.40 for the low group and 1.15 for the medium. The authors draw no inferences here, although it would be nice ...
after 2016. It is also why the NICE guidelines on high-risk women (BRCA1 and BRCA2) advise MRI ...
Sort results by: date | relevance
Click 
to remove filters
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
GPs practising in the UK can request to receive free copies of GP by completing our online registration form. For paid subscriptions to GP visit our subscriptions site.
To contact members of the GP team click here.
Haymarket Business Media © 1957 – 2012 | Terms & Conditions | Contact us
